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Abstract
Nocardiosis is a soil-borne aerobic infection caused by Nocardia species commonly affects the respiratory tract. 
Nocardia otitidis (N. otitidis) is the key organism for non-mycobacterial tuberculosis. The current study was attempted to 
investigate the effect of Mr. Trivedi’s biofield energy treatment on N. otitidis and analyzed for antimicrobial susceptibility 
pattern, minimum inhibitory concentration (MIC), DNA polymorphism by Random Amplified Polymorphic DNA (RAPD) 
and 16S rDNA sequencing. The strain of N. otitidis (ATCC 14630) was divided into two parts, control and treated. 
Antimicrobial susceptibility was studied using the broth microdilution technique. Overall, the MIC values of 16.67% 
antimicrobials were changed in the treated group of N. otitidis as compared to the control. Moreover, MIC value of 
trimethoprim/sulfamethoxazole was reduced by two-fold (0.5/9.5 to 0.25/4.75 µg/mL) in the biofield energy treated 
sample as compared to the control without alteration in the sensitivity spectrum. The 16S rDNA analysis showed that 
the treated sample was detected as Enterobacter aerogenes strain NCTC10006T (GenBank Accession No: AJ251468) 
with 98% identity of gene sequencing data. However, the nearest homolog genus-species was found as Kluyvera 
cryocrescens (GenBank Accession No: AM184245). Using RAPD biomarkers, the sample showed an average range of 
34 to 53% of polymorphism among treated samples as compared to the control. The 16S rDNA sequencing of treated 
sample was carried out to correlate the phylogenetic relationship of N. otitidis with other bacterial species. These 
results suggested that Mr. Trivedi’s biofield energy treatment has a significant impact on N. otitidis. 
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nocardiosis [9] in immunocompromised patients. Infectious Diseases 
Society of America (IDSA) reported that between 500 and 1,000 cases 
of Nocardial infections are recognized in the United States each year, of 
which 85% are serious pulmonary or systemic infections [10]. 
Since 1940s, the sulfonamides have been the drugs of choice for 
the treatment of nocardiosis [11]. Due to high mortality rate (50%) 
in patients with central nervous system (CNS) Nocardia infections 
(Nocardia brain abscess) and patients with non-CNS overwhelming or 
disseminated disease, the treatment strategy is inadequate. However, the 
combination of sulfamethoxazole with trimethoprim is often used as the 
drug of choice for the treatment of nocardiosis [12]. Therefore, some 
alternative strategies are needed to treat against nocardiosis. Biofield 
energy has been known as an alternative approach which may be useful 
as an alternative treatment to Nocardia infected patients. National 
Institute of Health/National Center for Complementary and Alternative 
Medicine (NIH/NCCAM) have reported that biofield (putative energy 
fields) or electromagnetic based energy therapies were commonly 
used to promote the health and healing [13]. Harold Saxton Burr had 
performed the detailed studies on the correlation of electric current 
with the physiological process and concluded that every single process 
in the human body had an electrical significance [14]. Recently, it was 
discovered that all the electrical processes happening in the human 
body have strong relationship with the magnetic field as required by 
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Introduction
The genus Nocardia is associated with the group of microorganisms 
known as the aerobic actinomycetes and belongs to the family of 
Mycobacteriaceae. Nocardia contains tuberculostearic acids but that 
differ from the mycobacteria by the possession of short-chain (40 to 
60 carbons) mycolic acids [1]. Nocardia otitidis (N. otitidis) is a weak 
filamentous Gram-positive, catalase-positive, branching rods shaped 
bacterium that appears similar to Actinomyces species. However, it 
can usually be differentiated from Actinomyces by acid-fast staining 
[2]. The taxonomic history of the genus Nocardia is controversial [3]. 
Nocardia typically exhibits varying degrees of acid fastness due to the 
presence of cell wall mycolic acid. The genus is typically similar to the 
genus of Mycobacterium. Mordarska et al. had studied the short-chain 
fatty acids content in the cell wall of Nocardia and Mycobacterium 
genera based on gas-liquid chromatography analysis did not find 
any difference between two genera [4]. Based on immunoblot and 
enzyme-linked immunosorbent assay (ELISA) techniques that detect 
specific antibodies that appear as common in various Nocardia and 
Actinomadura species. These antigens do not react with the antibodies 
produced in response to Mycobacterium tuberculosis infections [5]. 
Most of Nocardial infections occur in the United States due to inhalation 
of airborne spores or mycelial fragments from the environmental 
sources [6]. The most common manifestation of Nocardial disease is 
pulmonary nocardiosis [7], extrapulmonary disease [8], and ocular 
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Ampere’s law, which states that the moving charge produces magnetic 
fields in the surrounding space [15,16]. Thus, a human body emits the 
electromagnetic waves in the form of bio-photons that is also known 
as ultra-weak photon emissions (UPE). It surrounds the body and it 
is commonly known as biofield. Therefore, the biofield consists of an 
electromagnetic field, being generated by moving electrically charged 
particles (ions, cell, molecule, etc.) inside the human body [17]. The 
transfer of information from cell to cell or DNA or storage by biophotons 
has been demonstrated in plants, bacteria, animal neutriophil 
granulocytes and kidney cells [18]. Prakash et al. in 2015 reported that the 
various scientific instruments such as Kirlian photography, polycontrast 
interference photography (PIP) and resonance field imaging (RFI) can 
be extensively used to measure the biofield of human body [19]. Thus, 
human has the ability to harness the energy from the environment or 
universe and can transmit into any living or nonliving object(s) around 
the Globe. The objects always receive the energy and responding into 
the useful way that is called biofield energy and the process is known as 
biofield energy treatment. Mr. Mahendra Trivedi’s unique biofield energy 
treatment (The Trivedi Effect®) has been known to improve the overall 
productivity of crops [20,21], altered characteristics features of microbes 
[22-24], alter the structural, physical and thermal properties of several 
metals [25,26], and improved growth and anatomical characteristics of 
various medicinal plants [27,28].
Based on clinical significance of N. otitidis and significant impact 
of Mr. Trivedi’s biofield energy modality on microbes, the present work 
was undertaken to evaluate the impact of Mr. Trivedi’s biofield energy 
on N. otitidis in relation to antimicrobials susceptibility, minimum 
inhibitory concentration (MIC), random amplified polymorphic DNA 
analysis (RAPD) and 16S rDNA sequencing.
Materials and Methods
N. otitidis, American Type Culture Collection (ATCC 14630) strain 
was procured from Bangalore Genei, Bangalore-India in two vials A 
and B. Two different sealed packs were stored with proper storage 
conditions until further use. All the tested antimicrobials were procured 
from Sigma-Aldrich, India. The antimicrobial susceptibility and 
MIC were estimated with the help of broth micro dilution technique 
as per the Clinical Laboratory Standards Institute (CLSI) guidelines 
document number M24-A [29]. The 16S rDNA sequencing and DNA 
fingerprinting (RAPD) studies were carried out using Ultrapure 
Genomic DNA Prep Kit; Cat KT 83 (Bangalore Genei, India). 
Experimental design and biofield treatment strategy
N. otitidis strain was divided into two groups, i.e., control and 
treated. The treated group was in sealed pack and handed over to Mr. 
Trivedi for biofield energy treatment under laboratory conditions. Mr. 
Trivedi provided the treatment through his energy transmission process 
to the treated group without touching the sample. After treatment, 
control and treated groups were assessed on day 10 for antimicrobial 
susceptibility, and MIC. For RAPD analysis three inoculums (one for 
control and the other two for treated named as treated A and B) were 
prepared from N. otitidis samples. These two biofield treated samples 
A and B were sub-cultured by taking 1% inoculum and inoculated to 
fresh 5 ml medium and labeled as treatment A-1 and treatment B-1, 
respectively. The result of treated sample was compared with respect to 
the control. The 16S rDNA analysis was performed on biofield treated 
samples A and its subcultured sample A1.
Antimicrobial susceptibility test
The antimicrobial susceptibility testing is important for clinically 
significant species. The investigation of antimicrobial susceptibility of N. 
otitidis was carried out with the help of broth micro dilution technique, 
as per CLSI guidelines. Broth micro dilution was recommended 
for isolates of rapidly growing mycobacteria (RGM) based on CLSI 
published guidelines and recommendations for testing of non-
tuberculous mycobacteria (CLSI, M24-A, 2003) [29]. The detailed 
experimental procedure and conditions were followed as per the 
manufacturer’s instructions. The antimicrobial susceptibility pattern 
(S: Susceptible, R: Resistant) and minimum inhibitory concentration 
(MIC) were determined by observing the lowest antimicrobial 
concentration showing inhibition of growth.
Random amplified polymorphic DNA (RAPD) analysis
For DNA fingerprinting (RAPD) analysis all the treated samples 
(A, A1, B, and B1) were incubated at 37°C with 160 rpm for 18 h. 
Subsequently, the cultures were spun down, pelleted at 5000 rpm at 
40°C for 10 minutes and the genomic DNA was isolated for control 
and treated samples using Genomic DNA Prep Kit (Bangalore Genei, 
India). RAPD was performed with all samples of N. otitidis using five 
RAPD primers, which were labelled as RBA8A, RBA13A, RBA20A, 
RBA10A and RBA15A were adopted from earlier studies. The PCR 
mixture contained 2.5 μL each of buffer, 4.0 mM each of dNTP, 2.5 μM 
each of primer, 5.0 μL (approximately 20 ng) of each genomic DNA, 
2U each of Taq polymerase, 1.5 μL of MgCl2 and 9.5 μL of water in 
a total of 25 μL with the following PCR amplification protocol; initial 
denaturation at 94°C for 7 min, followed by 8 cycles of denaturation at 
94°C for 1 min, annealing at 35°C for 1 min, and extension at 72°C for 2 
min; and 35 cycle of denaturation at 94°C for 1 min, annealing at 38°C 
for 1 min, and extension at 72°C for 1.5 min; and the final extension 
at 72°C for 7 min. Amplified PCR products from all samples (control 
and treated) were separated on 1.5% agarose gels at 75 volts, stained 
with ethidium bromide and visualized under UV illumination [30]. The 
percentage of polymorphism was calculated using following equation: 
Percent polymorphism=A/B × 100
Where, A=Number of polymorphic bands in treated sample; and 
B=Number of polymorphic bands in control.
Amplification and gene sequencing of 16S rDNA 
Genomic DNA was isolated from N. otitidis cells (set A, sample coded 
as 9A) using genomic purification kit, according to the manufacturer 
instructions. 16S rDNA gene (~ 1.5 kb) fragment was amplified with the 
help of high-fidelity polymerase chain reaction (PCR) using universal 
primers; forward primer (5’-AGAGTTTGATCCTGGCTCAG-3’) and 
reverse primer (3’-ACGGTCATACCTTGTTACGACTT-5’). Amplified 
products were subjected to gel electrophoresis in 1.0% agarose gel, 
stained with ethidium bromide and visualized under UV light in a gel 
documentation unit (BioRad Laboratories, USA). The PCR amplified 
fragment was purified from the agarose gel using a DNA gel extraction 
kit. Sequencing of amplified product was done on a commercial basis 
from Bangalore Genei, India. The 16S rDNA sequences obtained were 
aligned and compared with the sequences stored in GenBank database 
available from National Center for Biotechnology Information (NCBI) 
using the algorithm BLASTn program. Multiple sequence alignment/
phylogenetic tree were established using MEGA3.1 molecular software 
[31].
Results and Discussion
Antimicrobial susceptibility test
Antimicrobial susceptibility pattern of Nocardia can vary from 
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species to species. The therapeutic effectiveness depends on the proper 
identification of species in infected patients and on in vitro sensitivity 
studies [32]. The antimicrobial sensitivity assay against Nocardia 
species had been especially considered in refractory cases. A standard 
test for antimicrobials sensitivity assessed by broth micro dilution and 
with cation-supplemented Mueller-Hinton broth has been approved by 
the National Committee for Clinical Laboratory Standards (NCCLS) 
[29]. The outcome of N. otitidis susceptibility pattern and MIC values of 
tested antimicrobials after biofield energy treatment are summarized in 
Table 1 and 2 respectively. The data were analyzed and compared with 
respect to the control. Study was carried out in twelve antimicrobials 
for assessment of antimicrobial susceptibility and MIC value. The 
treated cells of N. otitidis did not show any alteration with respect to 
antimicrobial susceptibility pattern as compared to the control (Table 
1). The susceptible nature of N. otitidis to amikacin, sulfamethoxazole, 
and ciprofloxacin and resistance pattern to ceftriaxone, amoxicillin-
clavulanic acid, and imipenem were well corroborated with the 
literature data [3]. Beside this, the MIC value of trimethoprim/
sulfamethoxazole was reduced by two-fold (0.5/9.5 to 0.25/4.75 µg/mL) 
in biofield energy treated sample as compared to the control sample. 
Moreover, the MIC value was slightly reduced (>32/16 to 32/16 µg/mL) 
in amoxicillin/k-clavulanate after the biofield therapy. Overall, 16.67% 
out of twelve antimicrobials showed an alteration of MIC values. Rest 
of the antimicrobials did not show any alteration of MIC values with 
respect to the control sample. Based on the literature, a combination 
of sulfa and antimalarial drugs, i.e., trimethoprim/sulfamethoxazole 
are the drug of choice against Nocardia infections as compared to the 
single sulfa drug [11,12]. In this experiment, the susceptibility nature 
of trimethoprim/sulfamethoxazole was constant in both controls as 
well as in treated sample, while the MIC value was reduced by two-
fold in treated sample after Mr. Trivedi’s biofield energy treatment. 
Hence, authors assumed that this improvement of MIC value without 
alteration of sensitivity pattern may be due to the effect of putative 
energy transmit through biofield healing (Table 2).
Random amplified polymorphic DNA (RAPD) analysis
The treated and control samples were identified on the basis of 
their different and discriminative RAPD patterns. RAPD is a preferred 
tool that is being used now days to correlate the genetic similarity 
or mutations between species. The simplicity and wide applicability 
of RAPD analysis mainly depend upon the use of short nucleotide 
primers, which were unrelated to known DNA sequences of the target 
organism [33]. DNA polymorphisms can be efficiently detected using 
the PCR primers and identify inter-strain variations among species in 
treated samples [34]. The degree of relatedness and genetic mapping 
can be correlated between similar or different treated sample species 
[35]. 
The DNA fingerprinting by RAPD analysis using five primers was 
carried out on the control and treated samples. DNA fingerprinting by 
RAPD analysis of the control and treated samples are shown in Figure 1, 
and the polymorphic bands are marked by arrows. The RAPD patterns 
of treated samples showed some unique and dissimilar patterns. DNA 
polymorphism analyzed by the RAPD analysis was presented in Table 3. 
The level of polymorphism between control and treated samples (A, A1, 
B, and B1) are summarized in Table 4. The level of polymorphism was 
found in an average range of 34 to 53% in treated samples as compared 
to control in N. otitidis after the biofield treatment. The highest change 
in DNA sequence was observed in treated groups with RBA 13A primer 
as compared to the control; a negligible change was found in treated 
group with RBA 8A primer as compared to the control (Table 3 and 4). 
16S rDNA genotyping
The bacteria that are poorly differentiated by conventional methods 
needs molecular analysis method like 16S rDNA sequence [36]. This 
molecular-based technique is a suitable tool for identification of most 
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Figure 1: Random amplified polymorphic-DNA fragment patterns of Nocardia 
otitidis generated using five RAPD primers, RBA 8A, RBA 13A, RBA 20A, RBA 
10A and RBA 15A. 1: Control; 2: Treated A; 3: Treated A-1; 4: Treated B; 5: 
Treated B-1; M: 100 bp DNA Ladder. 
S. No. Antimicrobial Control Treatment
1. Linezolid S S
2. Clarithromycin R R
3. Amikacin S S
4. Cefoxitin R R
5. Ceftriaxone R R
6. Imipenem R R
7. Minocycline S S
8. Tobramycin S S
9. Ciprofloxacin S S
10. Gatifloxacin S S
11. Amoxicillin/k-clavulanate R R
12. Trimethoprim/sulfamethoxazole S S
R: Resistant; S: Susceptible; Control: ATCC strain of N. otitidis (without biofield 
energy treatment); Treatment: ATCC strain of N. otitidis (with Mr. Trivedi’s biofield 
energy treatment)
Table 1: Antimicrobial susceptibility pattern of antimicrobials against ATCC strain of 
Nocardia otitidis after biofield treatment on day 10 as per CLSI guidelines.
S. No. Antimicrobial Control Treatment
1. Linezolid 2.0 2.0
2. Clarithromycin >32.0 >32.0
3. Amikacin <1.0 <1.0
4. Cefoxitin 256.0 256.0
5. Ceftriaxone 64.0 64.0
6. Imipenem 64.0 64.0
7. Minocycline 1.0 1.0
8. Tobramycin 8.0 8.0
9. Ciprofloxacin 4.0 4.0
10. Gatifloxacin 0.12 0.12
11. Amoxicillin/k-clavulanate >32/16 32/16
12. Trimethoprim/sulfamethoxazole 0.5/9.5 0.25/4.75
CLSI: Clinical and Laboratory Standards Institute; MIC values are presented 
as µg/mL; Control: ATCC strain of N. otitidis (without biofield energy treatment); 
Treatment: ATCC strain of N. otitidis (with Mr. Trivedi’s biofield energy treatment)
Table 2: Minimum inhibitory concentration (MIC) of antimicrobials against ATCC 
strain of Nocardia otitidis after biofield energy treatment on day 10 as per CLSI 
guidelines.
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of the bacteria on their genus and/or species level by comparison 
with databases in the public domain. Because, most of the bacteria 
have possess small ribosomal subunit with species-specific variability 
[37]. The 16S rDNA sequence was determined in treated samples of 
N. otitidis and coded as 9A and 9A1 (sub cultured sample), which are 
shown in Table 5. The alignment and comparison of the consensus 
gene sequences were performed with the sequences stored in GenBank 
database available from NCBI using the algorithm BLASTn program. 
Based on nucleotide homology and phylogenetic analysis of 
the microbe, the samples 9A and 9A1 (N. otitidis) were detected as 
Enterobacter aerogenes (GenBank Accession Number: AJ251468) with 
98% identity of gene sequencing data. The nearest homolog genus-
species of N. otitidis (9A and 9A1) was found as Kluyvera cryocrescens 
(Accession No. AM184245). Some other close homologs of N. otitidis 
were found from the alignment results as shown in Table 5. The distance 
matrix based on nucleotide sequence homology data are presented in 
Table 6. The phylogenetic tree was established using BLAST-Webpage 
(NCBI). According to Table 6, ten different related bacterial species 
of N. otitidis were selected as Operational Taxonomic Units (OTUs) 
in order to investigate the phylogenetic relationship of N. otitidis. 
There were 1462 base-pair nucleotides of 16S rDNA gene sequences, 
which were analyzed and multiple alignments were constructed using 
ClustalW in MEGA3.1 [31]. The numbers of base substitutions per site 
from pairwise distance analysis between sequences are shown in Table 
6. All the results were based on the pairwise analysis of 11 sequences. 
According to the data presented in Table 6, the lowest value of the 
genetic distance from N. otitidis was 0.018 base substitutions per site. 
This value is due to the distance between Enterobacter aerogenes and 
Kluyvera cryocrescens. All pairwise distance analysis was carried out 
using the p-distance method in MEGA3.1. The proportion of remarked 
distance, sometimes also called p-distance and showed as the number 
of nucleotide distances site. Values in Table 6 are programmed into 
Figure 2 with optimal bootstrap consensus tree. In the phylogram, there 
were eleven OTUs. The results suggested that after biofield treatment 
S. No. Primer Nucleotide Sequence (5′-3′) Band Scored
Common Bands in 
Control and Treated
Unique Band
Control TSA TSA-1 TSB TSB-1
1.   RBA 8A GTTTCGCTCC 19 - 1 1 5 1 -
2.  RBA 13A GTGGATCCGA 21 2 3 2 - 4 -
3.  RBA 20A GCGATCCCCA 15 2 3 1 - 4 -
4.  RBA 10A CCGCAGCCAA 19 - 2 3 1 3 -
5.  RBA 15A AAGAGCCCGT 25 2 2 3 - 1 -
TSA: Treated sample A; TSA-1: Treated sample A-1; TSB: Treated sample B; TSB-1: Treated sample B-1; -, No band
Table 3: DNA polymorphism analyzed by random amplified polymorphic DNA (RAPD) analysis.
Primer C and TSA C and TSA-1 C and TSB C and TSB-1 TSA and TSA-1 TSB and TSB-1 TSA and TSB TSA-1 and TSB-1
%
RBA 8A 15 53 15 7 53 7 0 46
RBA 13A 53 60 100 60 71 68 47 0
RBA 20A 50 35 57 35 22 33 7 0
RBA 10A 54 90 36 54 91 100 18 36
RBA 15A 56 31 25 18 52 62 31 13
Average polymorphism 45 53 46 34 57 54 20 19
C: Control; TSA: Treated Sample A; TSA-1: Treated Sample A-1; TSB: Treated Sample B; TSB-1: Treated Sample B-1
Table 4: Level of polymorphism between control and treated samples.
Alignment View AN Alignment Results Sequence Description
9A1 0.99 Sample studied
9A 0.89 Enterobacter aerogenes
AB244467 0.99 Enterobacter aerogenes strain: C1111
AB244456 0.98 Enterobacter aerogenes strain: An19-2
AJ251468 0.98 Enterobacter aerogenes strain NCTC10006T
AM184245 0.97 Kluyvera cryocrescens strain WAB1904
AJ251467 0.98 Klebsiella ornithinolytica strain JCM6096T
X93216 0.98 Klebsiella planticola strain DR3
AB364958 0.98 Raoultella ornithinolytica
AB353045 0.98 Klebsiella oxytoca strain: No.5
AB094655 0.98 Nocardia beijingensis strain: IFM 10052
AB094654 0.98 Nocardia beijingensis strain: IFM 0915
AN: GenBank Accession Number
Table 5: The closest sequences of Nocardia otitidis from sequence alignment using NCBI GenBank and ribosomal database project (RDP).
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followed by 16S gene sequencing, the coded sample (9A) was detected 
as Enterobacter aerogenes which was closely related to the Kluyvera 
cryocrescens with 98% similarity and the lowest genetic distance were 
0.018 base substitutions per site. Based on above findings, authors 
assumed the sustainability of The Trivedi Effect® in subcultured sample 
(9A1), as similar type of data was observed in the case of sub-cultured 
sample of N. otitidis. 
Due to microbial resistance to a single drug or multiple drugs, the 
invention of an effective antimicrobial therapy for the human-wellness 
is urgently required. However, due to some limitations of science, 
the progress of new medications is slow and very challenging for 
scientists. Biofield treatment might be responsible for doing alteration 
in microorganism at the genetic level and/or enzymatic level, which 
may act on the receptor protein. While altering the receptor protein, 
ligand-receptor/protein interactions may altered that could lead to 
show different phenotypic characteristics [38]. Based on these results, 
it is expected that biofield treatment has the scope to be a cost effective 
and alternative approach than the existing antimicrobial therapy in 
near future (Table 5 and 6).
Conclusions
Altogether, the biofield treatment has altered the MIC values 
(16.67%) of tested antimicrobials against the strain of N. otitidis. Using 
RAPD markers, the sample was characterized and showed interspecific 
relationships with N. otitidis after biofield treatment. The molecular 
method using 16S rDNA analysis showed that samples were detected as 
Enterobacter aerogenes (GenBank Accession Number: AJ251468) with 
98% identity of gene sequencing data that was nearest homolog species 
to Kluyvera cryocrescens (Accession No. AM184245). The results suggest 
that there is an impact of biofield treatment on MIC, 16S rDNA analysis, 
and DNA polymorphism of N. otitidis. These changes were found in the 
organism may be due to alterations happened at the genetic level after 
biofield treatment. Overall, it seems that Mr. Trivedi’s unique biofield 
energy treatment might be used as an alternate treatment approach in 
future antimicrobial therapy.
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